- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Insights 231 results
Client Alert
Client Alert
August 5, 2026
FDA’s New Psychedelic Drug Guidance Paves a Path to Approval While Setting a High Evidentiary Bar
Client Alert
August 4, 2026
2026 Rebate Model Pilot is an Inflection Point for 340B, HRSA
Client Alert
July 29, 2026
Challenging PCAOB Inspection Findings – Is Now the Time for a Change in Approach?
Client Alert
July 27, 2026
The FOCI Requirements Are Coming to Unclassified Defense Contracts: What Contractors Need to Know
Client Alert
July 8, 2026
Relationship Advice? Hide Your Confidential Information to Prevent Insider Trading.
Client Alert
July 7, 2026
New York Charts Its Course: NYDFS Proposes to Align Its Stablecoin Regime with the GENIUS Act
Client Alert
July 2, 2026
Treasury Sanctions Brazilian Criminal Network Linked to PCC Exploiting U.S. Financial System to Launder Drug Proceeds
Client Alert
July 1, 2026
California Extends SB 253 Greenhouse Gas Reporting Deadline and Signals Clarifying Rule Changes
Client Alert
June 30, 2026
FDA Signals Greater Flexibility for Single-Trial Drug Approvals
Client Alert
June 24, 2026
CMS Proposes Rule to Govern the “Medicare Drug Price Negotiation Program”
Client Alert
June 23, 2026
Defend and Advance: New Executive Orders Mobilize a Two-Front Federal Quantum Strategy